Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission (vol 30, pg 2796, 2024)


Por: Bengu N, Cromhout G, Adland E, Govender K, Herbert N, Lim N, Fillis R, Sprenger K, Vieira V, Kannie S, van Lobenstein J, Chinniah K, Kapongo C, Bhoola R, Krishna M, Mchunu N, Pascucci GR, Cotugno N, Palma P, Tagarro A, Rojo P, Roider J, Garcia-Guerrero MC, Ochsenbauer C, Groll A, Reddy K, Giaquinto C, Rossi P, Hong S, Dong K, Ansari MA, Puertas MC, Ndung'u T, Capparelli E, Lichterfeld M, Martinez-Picado J, Kappes JC, Archary M and Goulder P

Publicada: 1 may 2025 Ahead of Print: 1 feb 2025
Resumen:


Filiaciones:
Bengu N:
 Queen Nandi Regional Hospital, Empangeni, South Africa

 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Cromhout G:
 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

 Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa

Adland E:
 Department of Paediatrics, University of Oxford, Oxford, UK

Govender K:
 Africa Health Research Institute, Durban, South Africa

Herbert N:
 Department of Paediatrics, University of Oxford, Oxford, UK

Lim N:
 Department of Paediatrics, University of Oxford, Oxford, UK

Fillis R:
 Harry Gwala Regional Hospital, Pietermaritzburg, South Africa

Sprenger K:
 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Vieira V:
 Department of Paediatrics, University of Oxford, Oxford, UK

Kannie S:
 General Justice Gizenga Mpanza Regional Hospital, Stanger, South Africa

van Lobenstein J:
 General Justice Gizenga Mpanza Regional Hospital, Stanger, South Africa

Chinniah K:
 Mahatma Gandhi Memorial Hospital, Durban, South Africa

Kapongo C:
 Queen Nandi Regional Hospital, Empangeni, South Africa

Bhoola R:
 Harry Gwala Regional Hospital, Pietermaritzburg, South Africa

Krishna M:
 Harry Gwala Regional Hospital, Pietermaritzburg, South Africa

Mchunu N:
 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Pascucci GR:
 Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy

 Probiomics S.r.l., Rome, Italy

Cotugno N:
 Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy

 University of Rome Tor Vergata, Rome, Italy

Palma P:
 Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy

 University of Rome Tor Vergata, Rome, Italy

Tagarro A:
 Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain

 Department of Pediatrics, Infanta Sofia University Hospital and Henares University Hospital Foundation for Biomedical Research and Innovation, Madrid, Spain

 Universidad Europea de Madrid, Madrid, Spain

Rojo P:
 Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain

Roider J:
 LMU University Hospital, Munich, Germany

Garcia-Guerrero MC:
 IrsiCaixa AIDS Research Institute, Barcelona, Spain

Ochsenbauer C:
 University of Alabama at Birmingham, Birmingham, AL, USA

Groll A:
 TU Dortmund University, Dortmund, Germany

Reddy K:
 Africa Health Research Institute, Durban, South Africa

Giaquinto C:
 University of Padova, Padua, Italy

Rossi P:
 Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy

 University of Rome Tor Vergata, Rome, Italy

Hong S:
 Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA

Dong K:
 Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA

Ansari MA:
 Nuffield Department of Medicine, University of Oxford, Oxford, UK

:
 IrsiCaixa AIDS Research Institute, Barcelona, Spain

 Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain

Ndung'u T:
 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

 Africa Health Research Institute, Durban, South Africa

 Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA

 Division of Infection and Immunity, University College London, London, UK

Capparelli E:
 University of California San Diego, San Diego, CA, USA

Lichterfeld M:
 Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA

:
 IrsiCaixa AIDS Research Institute, Barcelona, Spain

 Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain

 Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain

 Infectious Diseases and Immunity Department, University of Vic-Central University of Catalonia, Vic, Spain

Kappes JC:
 University of Alabama at Birmingham, Birmingham, AL, USA

 Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL, USA

Archary M:
 Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa

Goulder P:
 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

 Department of Paediatrics, University of Oxford, Oxford, UK

 Africa Health Research Institute, Durban, South Africa

 Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA
ISSN: 10788956





Nature Medicine
Editorial
Nature Publishing Group, 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA, Reino Unido
Tipo de documento: Correction
Volumen: 31 Número: 5
Páginas: 1717-1717
WOS Id: 001415955600001
ID de PubMed: 39910274
imagen Green Submitted, hybrid

MÉTRICAS